A. Cohen

发表

Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering Effect

P. Meraj, G. Dangas, J. Badimón, 2000, Thrombosis and Haemostasis.

Risk factors for the development of slow flow during rotational coronary atherectomy.

G. Dangas, R. Mehran, J. Marmur, 1997, The American journal of cardiology.

Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography.

J. Machac, P. Meraj, G. Dangas, 2000, Coronary artery disease.

Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications.

G. Dangas, P. Toutouzas, C. Stefanadis, 2000, The American journal of cardiology.

Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial

Hester F. Lingsma, D. Nieboer, H. D. den Hertog, 2022, Trials.

Effect of Changes in Liver Blood Flow on the Pharmacokinetics of Saruplase in Patients with Acute Myocardial Infarction

R. Schoemaker, A. Cohen, W. Günzler, 1997, Thrombosis and Haemostasis.

Pharmacokinetics and Pharmacodynamics of Saruplase, an Unglycosylated Single-chain Urokinase-type Plasminogen Activator, in Patients with Acute Myocardial Infarction

A. Cohen, P. A. van der Wouw, R. Koster, 1994, Thrombosis and Haemostasis.

Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin.

P. Meraj, G. Dangas, J. Badimón, 1999, The American journal of cardiology.

Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect.

P. Meraj, G. Dangas, J. Badimón, 2000 .

The effect of early postinfarction revascularization of asymptomatic patients on left ventricular remodeling.

G. Dangas, J. Marmur, M. Goldman, 1999, Coronary artery disease.